Biomarkers Market Size, Share, Growth Analysis, By Product & Service(Consumables (Assay Kits, Reagents & Chemicals, Columns & Filters), Services), By Type(Safety Biomarkers, Efficacy Biomarkers (Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers), By Research Area(Genomics, Proteomics, Metabolomics, and Other Research Areas), By Technology(Immunoassays (ELISA, Protein Microarrays, Western Blot), NGS), By Disease Indication(Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders), By Application(Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research), By End User(Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Other End Users), By Region - Industry Forecast 2024-2031

Region-wise, North America held maximum share of the market in the past years and is expected to hold dominant share in future as well due to the prevalence of advanced healthcare infrastructure and increasing investments in biomarkers for more advancements. Key nations like Canada and the United States hold a mature and well-developed healthcare infrastructure comprising better diagnostic laboratories, superior research facilities, and a strong healthcare system. This infrastructure aids extensive research and development of biomarkers. Also, heavy investments from both private and public sectors are propelling R&D in North America. The leading companies operating in the region include Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific, Agilent Technologies Inc., and more.

Asia-Pacific region is expected to be the fastest-growing among others owing to increasing healthcare investments in research and infrastructure. Private sectors and governments are funding the improvements of biomedical research and the expansion of healthcare competencies, driving the development of biomarkers and adoption. Furthermore, the growing cases of chronic illnesses like diabetes, cardiovascular diseases, and cancer in the region are majorly demanding biomarkers for early detection, monitoring, and disease management. These factors are driving the biomarkers market in the region.